Franco Roviello

Franco Roviello

Graduation cum laude in Medicine and Surgery (MD degree) July 1987     

Postgraduate Training
October 1988-July 1993 – Surgical training in General and Emergency Surgery University of Siena – Nuovo Policlinico, Departments of Surgery – Siena (Italy) Sub-specialty training and certification in Gastrointestinal Oncologic Surgery

Accreditation in General Surgery July 1992

Academic Appointments
October 1991- 2005 – Assistant Professor, Lecturer – General Surgery (Joint academic and clinical appointment)

University of Siena School of Medicine Department of Surgical Oncology, Nuovo Policlinico University Hospital, Siena

October 2005-2013 – Associate Professor, Lecturer – General Surgery   (Joint academic and clinical appointment)

University of Siena School of Medicine, Department of Surgical Oncology,

October 2015 – Full Professor of Surgery, Senior Lecturer – General Surgery.

– Direttore U.O.C. Chirurgia Generale a Indirizzo Oncologico;
– Direttore f.f. DAI Oncologico;
– Direttore Scuola di Specializzazione in Chirurgia Generale Università di Siena;
– Coordinatore Progetto Chirurgia Miniinvasiva e Robotica AOUS;
– Segretario Generale SICO Societa Italiana di Chirurgia Oncologica;
– Associate Editor Upper GI European Journal of Surgical Oncology;


Nicola Fazio

Professional experience

Apr 2013 – today
Instituto Europeo di Oncologia, IEO, via Ripamonti 435, 20141, Milano
Director of Gastrointestinal Medical Oncology and Neuroendocrine Tumors Unit
Deputy Director of Hepatobiliary, Pancreatic and Digestive Program

Member of the following scientific societies:
Active Member of American Society of Clinical Oncology (ASCO)
Full Member of European Society for Medical Oncology (ESMO)
Member of European Neuroendocrine Tumour Society (ENETS)
Full member of Associazione Italiana di Oncologia Medica (AIOM)
Member of North American Neuroendocrine Tumor Society (NANETS)
Member of Società Italiana dei Tumori Neuroendocrini (ItaNET)

. Principal investigator of several research projects for National and International applications;
. Principal investigator of a number of clinical trials (phase I, II, III, IV, observational)
. Member of steering committees in some International clinical trials;
. Member of Editorial Board of the following scientific journals:
World Journal of Clinical Oncology (WJCO), European Journal of Oncology (EJO), Annals of Translational Medicine (ATM)
Peer Reviewer for the following scientific journals:
. Journal of Clinical Oncology, Lancet Oncology, Oncogene, Annals of Oncology, British Journal of Cancer, Oncology, Cancer, Neuroendocrinology, Scientific Reports, Journal of Surgical Oncology, Cancer Treatment Reviews, Critical Reviews in Oncology/Hematology, Clinical Gastroenterology and Hepatology, Tumori, International Journal of Endocrine Oncology, Journal of Nuclear Medicine, Journal of Oncology, Expert Opinion in Drug of Metabolism and Toxicology, The Breast, Expert Opinion on Pharmacotherapy, Endocrine, PLOS-one, EMJ Oncology, Digestive and Liver Disease, Oncotarget, Oncotargets and Therapy, Therapeutic Advances in Gastroenterology, Gastroenterology Research and Practice
. Invited speaker to a number of National and International scientific meetings, mainly about neuroendocrine tumors;
. Co-author of more than 100 publications in peer-review journals and some chapters of medical text-books;



Andre Berger


David Quinn

David Ian Quinn MBBS (Hons. I) PhD FRACP FACP undertook his early training at St. Vincent’s Hospital in Sydney before completing a PhD in Cancer Biology at the Garvan Institute and moving to the United States in 2000. Associate Professor Quinn is currently the Medical Director of the Norris Cancer Hospital and Clinics, Head, Section of Genitourinary Medical Oncology and Associate Professor of Medicine in the Division of Medical Oncology, Keck School of Medicine, University of Southern California. Prior experience includes Directorship of the Clinical Investigation Support Office and Leadership of the Genitourinary Cancer and Developmental Therapeutics Programs for the USC Norris Comprehensive Cancer Center.  He is a medical oncologist with focus in the field of clinical trials and molecular correlative studies in genitourinary cancer and early therapeutics.  David Quinn has published more than 100 papers, reviews and chapters including recent publications in New England Journal of Medicine, Lancet Oncology, Journal of the National Cancer Institute, Cell Stem Cells and Journal of Clinical Oncology. He is a reviewer for more than 50 peer-reviewed journals, is on the editorial boards of American Journal of Clinical Oncology, (American Society of Clinical Oncology), Clinical Genitourinary Cancer, Bladder Cancer  and Annals of Oncology and has been an invited speaker in more than 30 countries. Dr. Quinn is a member of the NCI Renal Cancer Task Force, Co-Chair for Genitourinary Cancer in the California Cancer Consortium and is SWOG organ site chair for advanced prostate cancer. His recent focus is on clinical trials and translation applications at USC and with SWOG and the California Cancer Consortium, where he has been principal investigator on more than 100 clinical trials for locally advanced and castrate-resistant prostate cancer, high grade urothelial cancer, advanced renal cell cancer, refractory germ cell tumors and adrenocortical carcinoma.



Gilberto Lopes

Gilberto de Lima Lopes Junior, MD, MBA, FAMS
Associate Professor of Clinical Medicine
Medical Director for International Programs
Associate Director for Global Oncology
Co-Leader, Lung Cancer Site Disease Group
Sylvester Comprehensive Cancer Center at the
University of Miami and the Miller School of Medicine

Gilberto Lopes, a medical oncologist, is the medical director for international programs and associate director for Global Oncology at the University of Miami Sylvester Comprehensive Cancer Center and associate professor at the Miller School of Medicine; and associate editor for ASCO University and for the society’s Journal of Global Oncology; he previously worked at the Johns Hopkins University.

Dr. Lopes has published more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, Nature Reviews, Lancet, Lancet Oncology and Health Affairs. In addition to delivering lectures around the world, he has been principal, co-Principal Investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary and thoracic cancers. His other main areas of research interest are health economics, value, policy and access to cancer drugs and treatment in low and middle income countries.

Dr. Lopes is currently a committee member for the International Association for the Study of Lung Cancer (IASLC), a member of the European Society of Medical Oncology expensive, innovative Medicines working group and the chair for the international clinical trials workshop working group and track leader for global health at the American Society of Clinical Oncology (ASCO), as well as an executive board member for the Latin American Cooperative Oncology Group (LACOG).

He has also served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization and advised governments, professional societies and industry on issues related to cancer control and treatment in low- and middle-income countries.



Javier Magrina

1998 – Present
Head – Division of Gynecologic Oncology, Department of Medical & Surgical Gynecology, Mayo Clinic, Scottsdale, Arizona

07/1998 – Present
Professor of Obstetrics and Gynecology – Mayo Clinic College of Medicine and Science

2015 – Present
Director – Fellowship in Minimally Invasive Gynecologic Surgery, Department of Medical & Surgical Gynecology, Mayo Clinic, Phoenix, Arizona

2015 – Present
Vice President – Minimally Invasive Gynecologic Surgery, Obstetrics & Gynecology, Programs in Arizona, Mayo Clinic, Phoenix, Arizona



Evandro de Azambuja

Evandro de Azambuja, MD, PhD
Head of Medical Support Team, Academic Promoting Team
Medical Oncologist, Breast Cancer Specialist, Institut Jules Bordet, Brussels, Belgium



Monish Aron

Dr. Monish Aron is an expert in robotic and laparoscopic surgery for malignant and benign conditions of the prostate, kidney, bladder, adrenal gland, and ureter. He trained in urology at some of the premier institutions in India, Australia, and the United States. Dr. Aron completed his fellowship training in advanced robotics and laparoscopy at the Cleveland Clinic, and was recruited to USC in 2009. He has received numerous acclaimed awards including the GB Ong Medal from the Royal College of Surgeons of Edinburgh, as well as several awards for his scientific presentations and surgical videos at the American Urological Association Congress. Dr. Aron has published extensively (>200 publications) and serves as reviewer for 8 leading urologic journals, including editorial board appointments for 3 journals. Dr. Aron has played a pioneering role in the development and refinement of robotic prostate and kidney surgery, single incision laparoscopic surgery, and robotic surgery for bladder cancer. Dr. Aron has been invited to speak at and demonstrate minimally invasive surgical techniques at numerous national and international institutions.


Virgilio Sacchini

Virgilio Sacchini, MD is Attending Surgeon, in the Breast Service of Memorial Sloan-Kettering Cancer Center in New York and  Full Professor of Surgery at the Weill Medical College of Cornell University in New York. He was vice-director of the  Breast Department at the European Institute of Oncology in Milan – Italy until September 2000. Dr. Sacchini received his medical degree from the University of Milan Medical School and trained in general surgery at the National Cancer Institute in Milan. In the last 15 years Dr. Sacchini has being involved as co-investigator in several clinical trials in breast cancer. He was Clinical co-ordinator of the Italian Breast Cancer Chemoprevention Study of Tamoxifen. He is participating as clinical investigator in some EORTC (European Organisation for Research and Treatment of Cancer) breast cancer trials.  It is in charge of some clinical trials on breast cancer at MSKCC. He is member at large of the Memorial Sloan Kettering Cancer Center Surgical Protocol Review and past member of the Quality Control and Quality Assurance, data and Safety Monitoring Committee, of Memorial Sloan Kettering Cancer Center. Dr. Sacchini has published more than 180 research papers and  chapter books.



Ben Solomon

Professor Ben Solomon MBBS, PhD, FRACP
Professor Ben Solomon is a medical oncologist at the Peter MacCallum Cancer Centre and Professor of Medicine at the University of Melbourne, Australia. Following a postdoctoral fellowship at the University of Colorado he returned to Peter MacCallum Cancer Centre in 2006 where he practices as a medical oncologist with a focus on clinical and translational research in lung cancer and phase I studies of novel anti-cancer therapies. He has been involved in the clinical development of targeted therapies in lung cancer, including the phase I through to phase III clinical trials with crizotinib that led to its approval in the treatment of ALK-rearranged NSCLC. He continues to be involvement in the development of novel ALK inhibitors and other novel targeted therapies and immunotherapies in NSCLC.



Daniela Cardinale

Education and PHD/Masters/Courses
Medicine Degree, University of Milan; specialization in Cardiology, University of Milan (with honours). PhD in Cardiovascular Physiopathology, University of Milan.

1987-1990: Internal Physician, Coronary Unit, Monzino Cardiology Centre, I.R.C.C.S, Milan
1990-1994: Consultant Cardiologist, Cardiology Division, S. Raffaele Hospital, I.R.C.C.S, Milan
1995-2001: Assistant Cardiologist, Cardiology Unit, European Institute of Oncology, I.R.C.C.S., Milan
2002-2004: Vice Director, Cardiology Unit, European Institute of Oncology, I.R.C.C.S, Milan
2005-2010: Senior Vice Director, Cardiology Unit, European Institute of Oncology, I.R.C.C.S., Milan
2011: Director, Cardioncology Unit, Division of Cardiology, European Institute of Oncology, Milan

Main fields of scientific interest
Cardio-toxicity caused by chemotherapeutics, Prevention and Treatment; Prevention and treatment of post-surgery atrial fibrillation

Author of more than 100 publications on national and international journals and reviser for the following scientific journals: Journal of American College of Cardiology, Heart, European Journal of Echocardiography, International Journal of Cardiology, Drug Safety, Haematologica, Journal of Chemotherapy, Italian Heart Journal.

Congresses and Teaching
Speaker at national and international conferences. Teacher at courses and seminars of the Italian Association of Hospital Cardiologists, of the Italian Society of Cardiology, of the Cardiovascular Clinical Biochemistry Study Group, of the School of Specialization in Cardiology of the University of Milan, of the Institute of Clinical Physiology of the C.N.R., of the Italian Society of Cardiovascular Echography, of the Italian Association of Medical Oncology, and of  the Italian Society of Haematology.



Daniel Przybysz

Dr. Przybysz MD is a Radiation Oncology Fellow at the Siteman Cancer Center / Washington University in St. Louis. He is also a Reviewer for the American Society of Radiation Oncology’ (ASTRO) Journals (i.e. Red Journal, PRO, Adv. RO) and for UpToDate.
Dr. Przybysz earned his Medical Degree from the Federal University of Parana (UFPR) conjointly with Harvard Medical School. Following his medical graduation, he did a Gynecology/Oncology Internship at the Massachusetts General Hospital as well as an Oncology Critical Care Internship at the MD Anderson Cancer Center.

Dr. Przybysz did his Radiation Oncology training at the National Cancer Institute of Brazil (INCA) with abroad rotations including the Washington University in St. Louis and The Royal Marsden Hospital in London, UK.

Dr. Przybysz has published more than 15 Clinical Research papers. Lung Cancer, IGRT, Proton Therapy and Adaptive Radiation Therapy are among his major topics.

Dr. Przybysz is currently a member of the American Society of Radiation Oncology (ASTRO), the Brazilian Society for Radiation Therapy (SBRT), the International Association for the Study of Lung Cancer (IASLC), the American Society of Clinical Oncology (ASCO) and the Radiology Society of North America (RSNA).

Presently, he is involved in Clinical Research projects regarding Lung SBRT and Adaptive Lung Radiation Therapy, Protons Hypo-Fractionation, GU and GI Adaptive Radiation Therapy. He leads the Lung Immunotherapy and Radiation Therapy Study Group at his institution.

He has been awarded with Harvard Medical School Phillip Vincent Award and has been recognized as a Leading Physician of The World by the International Association of Healthcare Professionals (IAHCP).